.
MergerLinks Header Logo

Announced

Pharmavite completed the acquisition of Bonafide Health for $425m.

Financials

Edit Data
Transaction Value£334m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Private

United States

Friendly

Majority

Single Bidder

Domestic

pharmaceutical

Pharmaceuticals

Completed

Synopsis

Edit

Pharmavite, a vitamin and supplement company, completed the acquisition of Bonafide Health, a women’s health company creating a new standard in managing the journey of menopause, for $425m. “We’re thrilled to welcome Bonafide Health to Pharmavite. This acquisition positions us as the nation’s leading women’s health nutraceutical company, signaling a new era of innovation and science-based solutions in this underserved space. Bonafide’s unwavering commitment to research, development, and robust scientific evidence mirrors Pharmavite’s rigorous standards, while its deep relationship with healthcare professionals aligns with our goal of ensuring nutrition education is at the forefront of the industry," Jeff Boutelle, Pharmavite CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US